KLRA 8-K 2026-08-12

Kailera Therapeutics, Inc. (KLRA) 8-K dated 2026-08-12 — accession 0001193125-26-346919.

Kailera Therapeutics, Inc. (KLRA) common stock.

Kailera Therapeutics, Inc. filed a 8-K on 2026-08-12. Accession 0001193125-26-346919.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for KLRA is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The KLRA SEC hub lists recent forms. The stock page is the research view.